Distance Learning

Digital Therapeutics: Emerging Legal, Regulatory, and Ethical Issues - Listen With a Colleague

The “Listen with a Colleague" option allows multiple registrants from the same organization and location to participate in the webinar at a discounted rate. It may ONLY be used if at least one person from your organization and location has registered at the regular/full webinar registration rate. Please note that those who register under the reduced “Listen with a Colleague" rate must access the webinar from the same location and computer as the full-priced registrant they are registered under.

The “Listen with a Colleague" option is continuing legal education (CLE) credit-eligible. In order to obtain a certificate of completion for submission to a state CLE accrediting body, those registered under this option must obtain the attendance verification code—which will be displayed at a random time during the webinar—and enter that code under “Verification Code for Live Webinar" section of the webinar description webpage. Please note that each registrant must submit a complete evaluation from their individual accounts to obtain a certificate of completion.

If you have any questions about this registration option, please contact customer support.

Time: 2:00-3:30 PM Eastern (90 minutes)
Session Format: Listen With a Colleague
CLE Credit Available:  Yes

This session will cover the following:

  • Evolving business models for digital therapeutics companies (and associated legal/regulatory issues)
    • direct-to-consumer
    • Digital providers/ .
    • partnerships/business arrangements (several examples of partnerships/business arrangements between big pharma, big data, payors, and startups)
  • Areas of Medicine Best Positioned for Digital Therapeutics
    • chronic diseases/behavioral
    • high-data/multifactorial diagnoses
    • other
  • Key legal/regulatory issues for digital therapeutics companies (FDA, FTC, privacy and security, fraud and abuse, and reimbursement)
  • Physician/Provider Use of Digital Therapeutics (and associated legal/regulatory issues)
    • standard of care
    • agreements between physicians/providers and digital therapeutics companies

  • Digital therapeutic providers supplying healthcare: contracting, status, obligations, risks. {This may be subsumed in "key legal/regulatory issues}.
  • The Future of Digital Therapeutics
    • emerging legal/regulatory and ethical issues (and some predictions)

Level of Difficulty: Advanced

  • AHLA Member: $99

Content Lead:

  • Life Sciences Practice Group
  • Registration Closed